IP Library Granted Patent US 8,703,489
Granted Patent B2
US 8,703,489 · App. 12/583,329 · Granted Apr 22, 2014

Methods and compositions for targeted single-stranded cleavage and targeted integration

Inventor: Jianbin Wang (San Ramon, CA)
Assignee: Sangamo BioSciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,489
App. No.
12/583,329
Granted
Apr 22, 2014
Kind
B2
Abstract

Disclosed herein are methods and compositions for generating a single-stranded break in a target sequence, which facilitates targeted integration of one or more exogenous sequences.

Claims (16)

1. A protein complex comprising:

(a) a first fusion protein comprising a DNA-binding domain and at least one catalytically inactive FokI cleavage domain or cleavage half-domain, wherein the cleavage domain or cleavage half-domain comprises a mutation at one or more of amino acid residues 450, 467 and 469; and

(b) a second fusion protein comprising a zinc finger domain and a FokI catalytically active cleavage half domain,

wherein the catalytically inactive FokI cleavage half domain forms a heterodimer with the catalytically active FokI cleavage half-domain of the second fusion protein and further wherein the protein complex induces a single-stranded break in a target double-stranded sequence.

2. A composition comprising one or more polynucleotides encoding the fusion proteins of the protein complex of claim 1 .

3. An isolated cell or cell line comprising a protein complex according to claim 1 .

4. A method of generating a single-stranded break in a target double-stranded sequence in a cell, the method comprising:

providing a composition according to claim 2 , wherein the heterodimer generates a single-stranded break in the target double-stranded sequence.

5. The method of claim 4 , wherein the target sequence is in cellular chromatin.

6. A method of inserting an exogenous sequence into a region of interest in a cell, the method comprising

generating a single-stranded break in the region of interest according to the method of claim 4 ; and

providing an exogenous sequence that is inserted into the region of interest following generation of a single-stranded break.

7. The method of claim 6 , wherein the exogenous sequence replaces a wild-type genomic sequence.

8. A method of inactivating a target sequence in a region of interest of a cell, the method comprising

generating a single-stranded break in the region of interest according to the method of claim 4 , and

providing an exogenous sequence that replaces the wild-type sequence in the region of interest and wherein the exogenous sequence partially or fully inactivates the target sequence.

Assignments (2)
CHANGE OF NAME Recorded Jul 20, 2018
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 046599/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2009
From: WANG, JIANBIN
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 023396/0426 →
Continuity (2)
Provisional Application 61189800 · Aug 22, 2008
Related Publication 20100047805A1 · Feb 25, 2010